Adopting Precision Diagnostics to Shape the Future of Oncology Therapies A Step Towards the Future of Advanced Therapies The AI-based analysis and digital imaging are believed to be advanced precision oncology therapies for the next generation to achieve potential and access to all patients. The...
Pfizer and Astellas' Positive Results Mark a Significant Improvement Image Credits: The Astellas US Newsroom Announcement Pfizer Inc. and Astellas Pharma Inc. proved their potential with the positive results directly from the overall survival (OS) analysis from its phase 3 study of EMBARK. A st...
Max Healthcare is Set to Flourish in the Healthcare Industry Image Credits: The Financial Express Efforts The hospital chain is expanding and focusing on growth in the Delhi-NCR region. The region is experiencing excellent growth in margins and ARPOB, and occupancy, which reflects the early day...
Novartis and Pan-Canadian’s Partnership has Finalized Negotiations Announcement Novartis Pharmaceuticals Canada Inc. finally confirms its partnership with Pan-Canadian Pharmaceutical by settling down with an effective negotiation on (Pcpa) public reimbursement of Cosentyx (secukinumab) for...
Pelthos Introduces New Medicine in the Healthcare Market Image Credits: eMPR Announcement Ligand Pharmaceuticals Incorporated partner Pelthos Therapeutics Inc has commercially introduced ZELSUVMI (berdazimer) topical gel 10.3%, which is an FDA-approved (at-home treatment) for molluscum contagio...
Connect Biopharma’s Partner Company to Submit its New Drug Application Announcement Connect Biopharma Holdings Limited, a biopharmaceutical company known for its unique care for the treatment of inflammatory disease, has proudly announced that its partner company, and a China-licensed comp...
Inventiva Announced a New Member for the Company Image Credits: The Pharma Letter Announcement Inventiva, a biopharmaceutical company known for the development of oral therapies mainly for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), is happy to experience a transit...
Biocytogen and BeOne Medicines’ Licensing Agreement Image Credits: Biocytogen Announcement Biocytogen [Pharmaceuticals Co., Ltd., a leading biotechnology company that excels in research and development of antibody-based drugs with its innovative technologies] has signed a licensing agreem...
The Proposed Public Offering of Rhythm’s Image Credits: AInvest Announcement Rhythm Pharmaceuticals Inc., a commercial-based biopharmaceutical company, has nearly improved the lives of rare neuroendocrine patients and has released the proposed public offering of $150 million of its common...
BioNxt Solutions' Overview of New Advancements in the Healthcare Market Image Credits: Irish Sun Announcement BioNxt Solutions Inc., a biopharmaceutical company known for its advanced drug-delivery technologies, has introduced a new advancement in the potential development, focusing on the chem...
